Find A Clinical Trial

Disease Type: Brain

Trial ID BDTX-1535
Sponsor ID Black Diamond Therapeutics

A Phase 1 Study to Assess BDTX-1535, an Oral EGFR Inhibitor, in Patients with Glioblastoma or Non-Small Cell Lung Cancer

1 Location